Blepharoptosis Blepharoptosis
Conditions
Interventions
The concentration of epinephrine in the local anesthetic was increased to 1:50,000.
D004926, D000764
Epinephrine, Local Anesthesia
Sponsors
Kakegawa Kyogo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 20 years or older. Patients who underwent bilateral blepharoptosis surgery (levator aponeurosis advancement).
Exclusion criteria
Exclusion criteria: Patients under 20 years of age. Patients who underwent unilateral surgery only. Patients who underwent blepharoptosis surgery using procedures other than levator aponeurosis advancement. Patients who had previously undergone blepharoptosis surgery at our institution or another institution and underwent the current procedure as a revision surgery. Patients diagnosed with congenital blepharoptosis. Patients with suspected underlying conditions such as myasthenia gravis, facial nerve palsy, or Horner syndrome. Patients receiving antithrombotic therapy who were unable to discontinue the medication during the perioperative period. Patients with thrombocytopenia (below the institutional reference range) or coagulation abnormalities due to other diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operative time (minutes) from skin incision to incision of the orbital septum, during which hemostatic procedures are primarily required. Because the amount of bleeding in this procedure is minimal, direct measurement of blood loss was deemed inappropriate as an outcome measure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary assessment of intraoperative bleeding Surgeon-rated operative field visibility score (Likert scale) The surgeon will comprehensively evaluate the surgical field from skin incision to incision of the orbital septum and record the score according to the following criteria: 1. Excessive bleeding, poor surgical field, and difficult manipulation 2. Moderate bleeding with reduced visibility 3. Some bleeding present but not interfering with the procedure (acceptable) 4. Minimal bleeding with a good surgical field 5. Almost no bleeding with an clear surgical field Total operative time (minutes) Number of bipolar cautery uses (times) Intraoperative parameters Total volume of local anesthetic used (mL) Maximum intraoperative systolic blood pressure (mmHg) Maximum intraoperative heart rate (beats/min) Change in systolic blood pressure (mmHg) from before local anesthesia to 10 minutes after administration Postoperative outcomes Postoperative hematoma (Cases requiring emergency wound reopening, hemostasis, and hematoma evacuation) Number of postoperative analgesic doses (loxoprofen) (times/10 doses) Severity of postoperative subcutaneous hemorrhage (ecchymosis) Evaluated at suture removal (7-14 days postoperatively) using the following 3-point scale 1. Ecchymosis extending beyond the upper eyelid 2. Ecchymosis involving more than half of the upper eyelid 3. Ecchymosis involving less than half of the upper eyelid Rate of undercorrection MRD-1 will be measured using frontal photographs taken immediately after surgery and at 1 month postoperatively, and the difference will be evaluated Presence or absence of reoperation within 6 months postoperatively Collected Patient Background Variables Age Sex Body mass index (BMI) Presence of hypertension Smoking history Presence of diabetes mellitus Use of antithrombotic agents (patients who were able to discontinue medication perioperatively will be included) Performance of lateral horn release Inpatient or outpatient surgery | — |
Contacts
Public ContactKyogo Kakegawa
Matsunami General Hospita
Outcome results
None listed